NASDAQ:XRTX Stock Quote
0.9700
+0.00 (0.00%)
Xortx Therapeutics Inc is a biotechnology company dedicated to developing innovative therapies for kidney-related conditions, particularly focused on diseases such as chronic kidney disease and metabolic disorders
The company aims to address significant unmet medical needs by advancing its proprietary drug candidates through clinical trials and bringing novel solutions to patients suffering from these challenging health issues. By leveraging advancements in science and technology, Xortx is committed to improving the quality of life for individuals impacted by kidney diseases.

As the regular session of the US market on Friday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · February 14, 2025

Via Benzinga · August 30, 2024

XORTX Therapeutics just reported results for the second quarter of 2024.
Via InvestorPlace · August 15, 2024

XORTX Therapeutics just reported results for the first quarter of 2024.
Via InvestorPlace · May 20, 2024
XORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical Trial
--News Direct--
Via News Direct · March 19, 2024

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company reported financial fourth-quarter EPS below estimates.
Via Benzinga · March 18, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<
Via Benzinga · January 4, 2024

Shares of United Natural Foods, Inc. (NYSE: UNFI) fell sharply during Wednesday’s session following second-quarter results.
Via Benzinga · March 6, 2024

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.
Via Benzinga · November 30, 2023

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via Benzinga · March 5, 2024

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to know about this morning!
Via InvestorPlace · October 24, 2023

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data.
Via Benzinga · October 24, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday.
Via Benzinga · October 24, 2023

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.
Via Benzinga · October 23, 2023

Okta stock is still falling on Monday as the company's shares suffer after it revealed a data breach of customer information.
Via InvestorPlace · October 23, 2023

U.S. stocks traded lower this morning, with the Dow Jones index falling over 100 points on Monday. Following the market opening Monday, The Dow traded down 0.41% to 32,991.58 while the NASDAQ fell 0.33% to 12,940.56. The S&P 500 also fell, dropping, 0.33% to 4,210.14.
Via Benzinga · October 23, 2023

Xortx Therapeutics stock is falling on Monday as the pharmaceutical company's shares retreat from a massive rally on Friday.
Via InvestorPlace · October 23, 2023

Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.
Via Benzinga · October 23, 2023

It's time to start off the workweek with a detailed breakdown of the biggest pre-market stock movers for Monday morning!
Via InvestorPlace · October 23, 2023

Xortx Therapeutics Inc. (NASDAQ: XRTX) shares are trading higher Friday on unusually heavy trading volume. Here's a look at what's going on:
Via Benzinga · October 20, 2023

Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares jumped 60.2% to $0.5101 after jumping 34% on Thursday.
Via Benzinga · October 20, 2023

Solar stocks are down on Friday and investors can look to Deutsche Bank are the reason for the slump in the sector today.
Via InvestorPlace · October 20, 2023

U.S. stocks traded lower this morning, with the Dow Jones index falling around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.17% to 33,357.23 while the NASDAQ fell 0.18% to 13,161.86. The S&P 500 also fell, dropping, 0.18% to 4,270.49.
Via Benzinga · October 20, 2023